Intrinsiqq
Skye Bioscience Inc. logo

Skye Bioscience Inc. Insider Trading

SKYE

Compare
Last 12 months

Insiders sold 445K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Andrew J. Schwab sold 240K on Sep 23, 13% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2023.

Net open-market
−445K
0 buys · 3 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
Aug 2023
Aug 29, 2023

Get an email when SKYE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 22 – 23No plan
    Andrew J. Schwab
    Director · sold 148,079 at avg $1.62
    240K
    13% of stake
  • Sep 22 – 23No plan
    5AM Ventures II LP
    Large holder · sold 148,079 at avg $1.62
    240K
    13% of stake
  • Sep 16No plan
    Andrew J. Schwab
    Director · sold 33,892 at avg $1.91
    65K
    2.9% of stake
  • Sep 16No plan
    Kush Parmar
    Large holder · sold 33,892 at avg $1.91
    65K
    2.9% of stake
  • Aug 18 – 20No plan
    Andrew J. Schwab
    Director · sold 375,840 at avg $0.37
    140K
    3.9% of stake
  • Aug 18 – 20No plan
    5AM Partners II, LLC
    Large holder · sold 375,840 at avg $0.37
    140K
    3.9% of stake
  • Aug 21, 2025 – Aug 22, 2025No plan
    Andrew J. Schwab
    Director · sold 231,405 at avg $3.46
    801K
    2.3% of stake
  • Aug 21, 2025 – Aug 22, 2025No plan
    Scott M Rocklage
    Large holder · sold 231,405 at avg $3.46
    801K
    2.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SKYE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SKYE

CompareIntrinsic value
ANVSAnnovis Bio, Inc.
$0.71-5.16%10
KTTAPasithea Therapeutics Corp.
$0.48-0.48%40
TPSTTempest Therapeutics Inc.
$0.29-5.36%0
PCSAProcessa Pharmaceuticals Inc.
$1.56-7.69%10
CPIXCumberland Pharmaceuticals Inc.
$5.84-7.30%20
GRIGri Bio Inc.
$1.12+0.00%20
PSTVPlus Therapeutics Inc
No recent price20
EVFMEvofem Biosciences Inc.
$1.00+0.00%15

Spot a number that looks wrong? Check it in SKYE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SKYE

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.